Search

Your search keyword '"Mitnaul, Lyndon J"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Mitnaul, Lyndon J" Remove constraint Author: "Mitnaul, Lyndon J"
49 results on '"Mitnaul, Lyndon J"'

Search Results

1. Plasma proteomic associations with genetics and health in the UK Biobank

2. Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank

3. Genetic Susceptibility to Mood Disorders and Risk of Stroke: A Polygenic Risk Score and Mendelian Randomization Study

4. “PMS2CL interference leading to erroneous identification of a pathogenic PMS2 variant in Black Patients”

5. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations

6. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

7. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

8. Polygenic Risk of Psychiatric Disorders Exhibits Cross-trait Associations in Electronic Health Record Data From European Ancestry Individuals

9. Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers

10. Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank

11. Multi-ethnic heterozygote frequencies of cancer susceptibility genes to inform counseling of reproductive risk

12. PMS2CL interference leading to erroneous identification of a pathogenic PMS2 variant in Black patients

13. Inference of Causal Relationships Between Genetic Risk Factors for Cardiometabolic Phenotypes and Female‐Specific Health Conditions

14. Analysis of rare genetic variation underlying cardiometabolic diseases and traits among 200,000 individuals in the UK Biobank

15. Genetic variation of the blood coagulation regulator tissue factor pathway inhibitor and venous thromboembolism among middle‐aged and older adults: A population‐based cohort study

16. Thrombotic risk determined by rare and common SERPINA1 variants in a population‐based cohort study

17. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia

18. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids

19. A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo1[S]

20. Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank

21. Classic Thrombophilias and Thrombotic Risk Among Middle‐Aged and Older Adults: A Population‐Based Cohort Study

22. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

24. Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study

25. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

26. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations

29. MEPE loss-of-function variant associates with decreased bone mineral density and increased fracture risk

30. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

32. Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline

33. Polygenic Risk of Psychiatric Disorders Exhibits Cross-trait Associations in Electronic Health Record Data From European Ancestry Individuals

34. Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype

36. Thrombotic risk determined by rare and common SERPINA1variants in a population‐based cohort study

37. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

38. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study

39. The Impact of Partial and Complete Loss-of-Function Mutations in Endothelial Lipase on High-Density Lipoprotein Levels and Functionality in Humans

40. An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top Of A Statin And Suppresses Hepatocyte SREBP-Regulated Genes

43. A β-Lactamase-Dependent Gal4-Estrogen Receptor β Transactivation Assay for the Ultra-High Throughput Screening of Estrogen Receptor β Agonists in a 3,456-Well Format

45. A β-Lactamase-Dependent Gal4-Estrogen Receptor βTransactivation Assay for the Ultra-High Throughput Screening of Estrogen Receptor βAgonists in a 3,456-Well Format

46. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure

48. Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors.

49. A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format.

Catalog

Books, media, physical & digital resources